ETHYL 4-(BROMOMETHYL)-2-(((2,6-DIFLUOROPHENYL)METHYL)(PROPOXYCARBONYL)AMINO)-5-(4-NITROPHENYL)-3-THIOPHENECARBOXYLATE
UNII 6K3T3H4GJ9

Substance Identification & Data

This profile provides standardized clinical and technical data for Ethyl 4-(bromomethyl)-2-(((2,6-difluorophenyl)methyl)(propoxycarbonyl)amino)-5-(4-nitrophenyl)-3-thiophenecarboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 6K3T3H4GJ9.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2591260-07-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

6K3T3H4GJ9

CAS Registry Number

2591260-07-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ETHYL 4-(BROMOMETHYL)-2-(((2,6-DIFLUOROPHENYL)METHYL)(PROPOXYCARBONYL)AMINO)-5-(4-NITROPHENYL)-3-THIOPHENECARBOXYLATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C25H23BrF2N2O6S

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QPNRMDOVFXGOFY-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

176486497

Unique identification number in the NCBI database of chemical substances.

Substance Type

Ethyl 4-(bromomethyl)-2-[[(2,6-difluorophenyl)methyl](propoxycarbonyl)amino]-5-(4-nitrophenyl)-3-thiophenecarboxylate

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

CCCOC(=O)N(Cc1c(cccc1F)F)c2c(c(CBr)c(-c3ccc(cc3)[N+](=O)[O-])s2)C(=O)OCC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ethyl 4-(bromomethyl)-2-(((2,6-difluorophenyl)methyl)(propoxycarbonyl)amino)-5-(4-nitrophenyl)-3-thiophenecarboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.